CSL, from blood stock to blue chip
Ian D Gust
+ Author Affiliations
- Author Affiliations
Department of Microbiology and Immunology, The University of Melbourne, L1 766 Elizabeth Street, Melbourne, Vic. 3000, Australia. Tel.: +61 3 8344 3963, Fax: +61 3 8344 6452, Email: idg@unimelb.edu.au
Microbiology Australia 41(4) 183-186 https://doi.org/10.1071/MA20050
Published: 16 October 2020
Abstract
From its modest beginning in 1916 with a staff of 20, CSL has grown into a major company, which now employs more than 25,000 people, operates in more than 70 countries and has a market capitalization of over A$130 billion.
